Venofer (iron sucrose injection, USP)

Published Online: Monday, May 1, 2006

American Regent Inc (Shirley, NY) recently received FDA approval for 2 new indications for Venofer. The product was initially approved for use in the treatment of iron deficiency anemia in hemodialysis (HD) patients receiving an erythropoietin. Venofer now also is indicated for the treatment of iron deficiency anemia in peritoneal dialysis (PD) patients receiving an erythropoietin and in nondialysis chronic kidney disease (CKD) patients receiving or not receiving an erythropoietin. The product can be administered via an intravenous push (100-mg [HD] and 200-mg [CKD] doses) or by infusion (300- and 400-mg doses [PD]) depending on the indication. Venofer is available in 100-mg/5-mL single-dose vials. For more information, visit, or call 800-645-1706.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues